1
|
Laforgue EJ, Bulteau S, Cholet J, Victorri-Vigneau C, Guitteny M, Mauduit N, Vanelle JM, Sauvaget A. [Concordance between hospital prescriptions and recommendations in the treatment of mania]. Therapie 2016; 72:327-337. [PMID: 27726886 DOI: 10.1016/j.therap.2016.07.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2016] [Revised: 06/27/2016] [Accepted: 07/08/2016] [Indexed: 11/18/2022]
Abstract
PURPOSE There are differences between recommendations and practice in the pharmacological treatment of acute mania. OBJECTIVE The objective was to assess conformity of the anti-manic prescription between national recommendations (Haute Autorité de santé [French health authority, HAS] and "résumé des caractéristiques du produit" [product characteristics, RCP]) and clinical practice. METHODS We observed the drug prescriptions of in-patients for a manic episode. The main outcome measure was the concordance rate with the recommendations of the drugs prescriptions at the 48th hour. The secondary outcome repeated the same process with the hospital discharge statement of switches, associations, the presence of symptomatic and antidepressant treatments. RESULTS Sixty-six episodes were included, 40 patients (60%) had a prescription complies with RCP recommendations H48 and 46 patients (70%) to HAS. These rates fall at hospital discharge. CONCLUSIONS Off-label prescriptions, drug combinations and choices of not listed molecules are the most common reasons for non-conformity.
Collapse
Affiliation(s)
- Edouard-Jules Laforgue
- Centre d'évaluation et de traitement des troubles de l'humeur complexes, CAPPA Jacques-Prévert, Hôtel-Dieu, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France.
| | - Samuel Bulteau
- Centre d'évaluation et de traitement des troubles de l'humeur complexes, CAPPA Jacques-Prévert, Hôtel-Dieu, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
| | - Jennyfer Cholet
- Service universitaire d'addictologie, hôpital Saint-Jacques, CHU de Nantes, 44093 Nantes, France; EA 4275 SPHERE « bioStatistics, Pharmacoepidemiology and Human sciEnces REsearch », faculté de médecine et pharmacie, université de Nantes, 44093 Nantes, France
| | - Caroline Victorri-Vigneau
- EA 4275 SPHERE « bioStatistics, Pharmacoepidemiology and Human sciEnces REsearch », faculté de médecine et pharmacie, université de Nantes, 44093 Nantes, France; Service de pharmacologie clinique, institut de biologie, CHU de Nantes, 9, quai Moncousu, 44093 Nantes, France
| | - Marie Guitteny
- Centre d'évaluation et de traitement des troubles de l'humeur complexes, CAPPA Jacques-Prévert, Hôtel-Dieu, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France
| | - Nicolas Mauduit
- Service d'information médicale, CHU de Nantes, immeuble Deurbroucq, 44093 Nantes, France
| | - Jean-Marie Vanelle
- Centre d'évaluation et de traitement des troubles de l'humeur complexes, CAPPA Jacques-Prévert, Hôtel-Dieu, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France; Service d'information médicale, CHU de Nantes, immeuble Deurbroucq, 44093 Nantes, France
| | - Anne Sauvaget
- Centre d'évaluation et de traitement des troubles de l'humeur complexes, CAPPA Jacques-Prévert, Hôtel-Dieu, CHU de Nantes, 1, place Alexis-Ricordeau, 44093 Nantes cedex 1, France; EA 4275 SPHERE « bioStatistics, Pharmacoepidemiology and Human sciEnces REsearch », faculté de médecine et pharmacie, université de Nantes, 44093 Nantes, France
| |
Collapse
|